/
Functional abdominal pain in children Functional abdominal pain in children

Functional abdominal pain in children - PowerPoint Presentation

Soulreaver
Soulreaver . @Soulreaver
Follow
344 views
Uploaded On 2022-08-04

Functional abdominal pain in children - PPT Presentation

David Suskind MD Associate Professor of Pediatrics Division of Gastroenterology Hepatology and Nutrition University of Washington Seattle Childrens Hospital Disclosure Statement I do not have any financial interest arrangement or affiliation with medicalpharmaceuticalequipment companie ID: 934829

abdominal pain functional children pain abdominal children functional symptoms group criteria treatment ibs months evidence gastroenterology therapy placebo gastroenterol

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Functional abdominal pain in children" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Functional abdominal pain in children

David Suskind M.D.

Associate Professor of Pediatrics

Division of Gastroenterology Hepatology and Nutrition

University of Washington

Seattle Children’s Hospital

Slide2

Disclosure Statement

I do not have any financial interest, arrangement or affiliation with medical/pharmaceutical/equipment companies

Slide3

Objectives

Understand the definition and classification of pain predominant functional gastrointestinal disorders

Synthesize various factors involved in their pathophysiology

Apply the pathophysiology principles in understanding evidence based treatments

Slide4

Epidemiology - Functional GI Disorders

Vast majority of ALL childhood abdominal pain is functional

2-4% of all general pediatric visits

>50% of consultations in pediatric GI

Frequently misdiagnosed

Significant morbidity

Quality of life substantially poorer than in those suffering from asthma or migraine

Slide5

What’s in a name?

Slide6

All roads lead to Rome

Rome III abdominal pain-related FGIDs

Functional dyspepsia

Irritable bowel syndrome

Abdominal migraine

Childhood functional abdominal pain

Slide7

Diagnostic Criteria for Functional Dyspepsia

1

. Persistent or recurrent pain or discomfort centered in the upper abdomen (above the umbilicus)

2. Not relieved by defecation or associated with the onset of a change in stool frequency or stool form (i.e., not IBS)

3. No evidence of an inflammatory, anatomic, metabolic, or neoplastic process that explains the subject’s symptoms

* Criteria fulfilled at least once per week for at least 2 months before diagnosis

Slide8

Diagnostic Criteria for Irritable Bowel Syndrome (IBS)

Abdominal discomfort or pain associated with 2 or more of the following at least 25% of the time:

Improved with defecation

Onset associated with a change in frequency of stool

Onset associated with a change in form (appearance) of stool

No evidence of an inflammatory, anatomic, metabolic, or neoplastic process that explains the subject’s symptoms

* Criteria fulfilled at least once per week for at least 2 months before diagnosis

Slide9

Diagnostic Criteria for Abdominal Migraine

Paroxysmal episodes of intense, acute periumbilical pain that lasts for 1 hour or more

Intervening periods of usual health lasting weeks to months

The pain interferes with normal activities

The pain is associated with 2 or more of the following:

Anorexia b. Nausea c. Headache

d. Photophobia d. Pallor

No evidence of an inflammatory, anatomic, metabolic, or neoplastic process that explains the subject’s symptoms

* Criteria fulfilled at least once per week for at least 2 months before diagnosis

Slide10

Diagnostic Criteria for Childhood Functional Abdominal Pain

Episodic or continuous abdominal pain

Insufficient criteria for other FGIDs

No evidence of an inflammatory, anatomic, metabolic, or neoplastic process that explains the subject’s symptoms

* Criteria fulfilled at least once per week for at least 2 months before diagnosis

Slide11

“A Prescription for Abdominal Pain: Due Diligence”

By Perri Klass, M.D. 11/22/2010

The stomachache people look with some envy at the headache people.

“For some reason people respect headaches,” said Dr. Carlo Di Lorenzo, a leading pediatric gastroenterologist and professor of clinical pediatrics at Ohio State. “I’ve never seen a parent or a pediatrician tell a child complaining of a headache, ‘You don’t have a headache – it’s not real.’ Bellyache is just as real as headache.”’

Slide12

“It’s all in your head”

Slide13

“It’s all in your head

Slide14

Slide15

Pathophysiology

Slide16

Visceral Hypersensitivity

Distention and excessively strong contractions are primary causes of digestive tract pain

Detected by mechanoreceptors

Hypersensitivity found in substantial subset of patients with IBS/FGID

Balloon inflation during sigmoidoscopy and endoscopy

Modulated by 5-HT

3

“Wind-up” / central sensitization phenomenon

Slide17

Early Life Events and Visceral Hypersensitivity

Pain sensing neuronal circuits are formed during the neonatal period

Adverse events early in life may “prime” a child for chronic abdominal pain

Trauma/surgery?

Stress?

Cow’s milk allergy?

Saps et al.

J

Pediatr

Gastroenterol

Nutr

2011;52:166-9

Slide18

Motility

Strong contractions during power propulsion underlie sensation of cramping abdominal pain

Power propulsion occurs more frequently and with stronger force in those with IBS with diarrhea

Chey

et al.

Am J

Gastroenterol

2001;96:1499-506.

Prolonged colonic transit time in those with IBS and constipation

Agrawal

et al.

Am J

Gastroenterol

2009;104:998-2004.

Slide19

Altered Gastrointestinal Flora

Qualitative and quantit

a

tive changes in gut flora have been described in IBS patients

Lower level of Lactobacillus spp. in IBS-diarrhea

Higher rates of small bowel bacterial overgrowth

Patients who received antibiotics in the previous months are 3 times more likely to develop functional symptoms

Slide20

Altered Gastrointestinal Flora

Post-infectious IBS

36% of children with bacterial gastroenteritis met criteria for FGID 6 months later (vs 11% of controls)

Changes in flora may alter visceral perception and motility

Saps et al

. J Peds

2008;152:812-816

Slide21

Psychological Factors

Slide22

Psychological Factors

Relationships

Pain Mastery

+

+

-

-

Walker et all.

Pain

2006;122:43-52.

Slide23

Parenting Techniques

Aim: to assess the impact of parent attention versus distraction on symptom complaints

Walker et al.

Pain

2006;122:43-52.

Slide24

Parenting Techniques

Aim: to assess the impact of parent attention versus distraction on symptom complaints

Included children with and without FAP

Water load provocation to induce pain

Parents randomly assigned/trained to: attention, distraction, or no instruction

Self-reported GI symptoms recorded before and after parent interaction

Parents’ and children’s perceptions of their interaction were assessed

Walker et al.

Pain

2006;122:43-52.

Slide25

Study Results

Symptom complaints by both FAP and well children:

Nearly doubled in the ‘Attention’ group

Reduced by half in the ‘Distraction’ group

Children in the ‘Distraction’ group rated parents as making them feel much better than ‘Attention’ group

Parents rated distraction as having greater potential negative impact on their children than attention

Walker et al. Pain 2006;122:43-52

Slide26

Pathophysiology - Review

Biopsychosocial model

Visceral hypersensitivity

Central sensitization / “Wind-up” phenomenon

Possible effect from early life events

Motility disturbance

Altered gastrointestinal flora

Psychologic factors, including coping strategies

Parenting techniques

Slide27

Natural History

Slide28

Natural History

Children with RAP seen by a subspecialist more likely to have anxiety, depression, and migraine headaches as adults

Campo et al.

Pediatrics

2001:108:e1

35% of children with FAP (N=188) had persistent FGID at follow-up 4-15 years later

Prevalence of

non-GI

somatic complaints associated with persistent functional disease

Dengler-Crish

et al. .

J

Pediatr

Gastroenterol

Nutr

2011;52:162-5.

Slide29

Making the diagnosis

History

Children with FAP are

more

likely to have headache, joint pain, anorexia, nausea, excessive gas, and altered bowel habits

Yet none of these symptoms can distinguish functional from “organic” abdominal pain

Slide30

Alarm Symptoms

Involuntary weight loss or growth failure

Dysphagia

Frequent vomiting

Chronic, severe diarrhea

Nocturnal symptoms, especially BM’s

Persistent RUQ or RLQ pain

Rectal bleeding without constipation

Slide31

Appropriate work-up

Predictive value of blood tests not well studied

No evidence that ultrasound of abdomen/pelvis has significant yield

EGD

NOT

indicated without alarm symptoms

Subcommittee on Chronic Abdominal Pain.

Pediatrics

2005;40:249-61.

Negative EGD does not reassure /improve outcome

Bonilla et al

.

Clin

Pediatr

2011;(

epub

ahead of print).

Slide32

Treatment

Pharmacotherapy

Probiotics

Psychological

Cognitive Behavioral Therapy

Hypnotherapy

Biofeedback

Complementary and Alternative

Acupuncture

Slide33

Pharmacotherapy

“Primum non nocere”

Slide34

Peppermint Oil

RDBPCT of 42 children with IBS

Enteric coated peppermint oil capsules vs placebo

After 2 weeks, 75% of peppermint oil group had decreased severity of pain vs 19% with placebo

Limitations

Short study

Entry criteria not well described

Kline et al.

J

Pediatr

2001;138:125-8.

Slide35

Antibiotics

Rifaximin

2 DBPCTs randomized 1260 patients to rifaximin (550 mg TID) or placebo x 2 weeks

Primary endpoint = proportion with self-reported relief for at least 2 of the 4 weeks immediately post treatment

40% relief with rifaximin vs 31% with placebo (p<0.001)

Effect “persisted” at 12-week follow-up

Pimentel et al.

NEJM

2011;364:22-32.

Slide36

Rifaximin

Slide37

Probiotics

RCT of

Lactobacillus GG

(LGG) vs placebo in children with FAP or IBS

N = 144 (9 primary care sites and 1 referral center)

LGG (3x10

9

BID) vs placebo for 8 weeks

8-week follow-up phase

LGG but not placebo significantly reduces the frequency (p<0.01) and severity (p<0.01) of abdominal pain by end of treatment

Effects persisted at 8-week follow-up

Francavilla

et al.

Pediatrics

2010;126:e1445-52.

Slide38

Lactobacillus GG

Slide39

Amitriptyline

Children with FAP, IBS, or functional dyspepsia randomized to 4 weeks placebo or amitriptyline

10 mg/d, weight <35 kg; 20 mg/day, weight >35 kg

Pain, psychological traits, and daily activities assessed before and after intervention

Primary outcome = self assessment of pain relief and sense of improvement

Saps et al.

Gastroenterology

2009;137:1261-9.

Slide40

Slide41

Cognitive Behavioral Therapy

200 children/parents with FAP randomized to :

3 session intervention of CBT: relaxation training; modifying response to illness/wellness; altering dysfunctional thoughts about symptoms

3 session education intervention controlled for time and intervention

Children and parents assessed pre-treatment and serially up to 6 months post-treatment

Outcome measures: child and parents reports of pain levels, function, and adjustment

Levy et al.

Am J

Gastroenterol

2010;105:946-956.

Slide42

CBT - Results

CBT group with greater baseline to follow-up decrease in pain and GI symptoms (p<0.01)

CBT parents with greater decreases in solicitous responses to child’s symptoms (p<0.0001

)

Levy et al.

Am J Gastroenterol

2010;105:946-956.

Slide43

Hypnotherapy

Vlieker et al.

Gastroenterology

2007;133:1430-1436.

Slide44

Hypnotherapy - Study design

Gut directed hypnotherapy (HT)

Single experienced provider

6 sessions of 50 minutes over a 3-month period

Specific protocol, adapted to child’s developmental age

Control of gut functions

General relaxation

Ego strengthening suggestions

Provided with CD and encouraged to practice self-hypnosis

Standard medical therapy (SMT)

Education

Dietary advice and added fiber

“Pain medications” or PPIs, if necessary

6 therapy sessions to explore stressful factors and/or triggers

Vlieger

et al.

Gastroenterology

2007;133:1430-1436.

Slide45

Study Design - Outcomes

Pain intensity and frequency measured serially up to 12 months after therapy

Remission: >80% decrease in pain intensity and frequency scores

Vlieger

et al.

Gastroenterology

2007;133:1430-1436.

Slide46

Figure 2.

Changes in pain intensity scores during and after treatment

Vlieger

et al.

Gastroenterology

2007;133:1430-1436.

Slide47

Figure 3.

Changes in pain frequency scores during and after treatment

Vlieger

et al.

Gastroenterology

2007;133:1430-1436.

Slide48

Vlieker et al.

Gastroenterology

2007;133:1430-1436.

Table 2. Percentage of Patients in Clinical Remission

After therapy At 6 mo follow-up At 1 yr follow-up

SMT group HT group SMT group HT group SMT group HT group

(n = 25) (n = 27) (n = 24) (n = 27) (n = 24) (n = 27)

No effect 56% 15% 66% 7% 46% 4%

Improved 32% 26% 17% 22% 29% 11%

Clinical remission 12% 59% 17% 71% 25% 85%

P < .001 between the treatment groups at all end points.

Slide49

Biofeedback

Excellent evidence for chronic headaches

Data lacking for abdominal pain, but seems to work!

Slide50

Complementary Medicine

Acupuncture

Slide51

Complementary Medicine

Acupuncture

Magge and Lembo

. Gastroenterol Clin N Am

2011;40:245-253.

Slide52

Treatment - Conclusions

Peppermint oil may have some role

Emerging data for efficacy of probiotics

Psychological based treatment, particularly cognitive behavioral therapy and gut directed hypnotherapy are the most effective, evidence-based treatments

Slide53

Summary

Almost all chronic abdominal pain in children is functional

Concept should be introduced to families early

It’s not just “in your head!”

Cognitive behavioral therapy and hypnotherapy are the most evidence-based therapies

Key to effective treatment is the patient-physician relationship